SBDS expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.938300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.266080E-02
Normal-vs-Stage2
5.533700E-02
Normal-vs-Stage3
3.739800E-01
Normal-vs-Stage4
3.893900E-02
Stage1-vs-Stage2
9.688600E-01
Stage1-vs-Stage3
6.286800E-01
Stage1-vs-Stage4
1.045030E-01
Stage2-vs-Stage3
5.385600E-01
Stage2-vs-Stage4
5.060000E-02
Stage3-vs-Stage4
2.033800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.180500E-02
Normal-vs-AfricanAmerican
9.536100E-02
Normal-vs-Asian
3.986600E-01
Caucasian-vs-AfricanAmerican
4.303200E-01
Caucasian-vs-Asian
1.694170E-01
AfricanAmerican-vs-Asian
2.859400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.518100E-02
Normal-vs-Female
3.571600E-02
Male-vs-Female
5.951000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.826300E-02
Normal-vs-Age(41-60Yrs)
7.963400E-03
Normal-vs-Age(61-80Yrs)
1.124820E-01
Normal-vs-Age(81-100Yrs)
9.124600E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.143200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.759400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.937200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.575970E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.458580E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.443600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.392170E-01
Normal-vs-Daily Drinker
9.747700E-02
Normal-vs-Weekly Drinker
1.923830E-01
Normal-vs-Occasional Drinker
2.594100E-02
Normal-vs-Social Drinker
7.705700E-02
Non Drinker-vs-Daily Drinker
9.085200E-01
Non Drinker-vs-Weekly Drinker
5.187200E-01
Non Drinker-vs-Occasional Drinker
2.023800E-01
Non Drinker-vs-Social Drinker
1.880560E-01
Daily Drinker-vs-Weekly Drinker
5.190600E-01
Daily Drinker-vs-Occasional Drinker
1.493160E-01
Daily Drinker-vs-Social Drinker
1.556000E-01
Weekly Drinker-vs-Occasional Drinker
7.509600E-01
Weekly Drinker-vs-Social Drinker
6.612000E-01
Occasional Drinker-vs-Social Drinker
8.169800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.154000E-01
Normal-vs-Grade 2
5.952500E-02
Normal-vs-Grade 3
5.300400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.387590E-01
Grade 1-vs-Grade 3
2.069000E-01
Grade 1-vs-Grade 4
2.154000E-01
Grade 2-vs-Grade 3
8.706200E-01
Grade 2-vs-Grade 4
5.952500E-02
Grade 3-vs-Grade 4
5.300400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.705160E-01
Normal-vs-NonDiabetic
3.611600E-02
Diabetic-vs-NonDiabetic
1.971160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.010200E-02
Normal-vs-NoPancreatitis
5.986000E-02
Pancreatitis-vs-NoPancreatitis
3.869400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.755900E-02
Normal-vs-N1
5.470500E-02
N0-vs-N1
9.820000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.458500E-02
Normal-vs-TP53-NonMutant
1.006430E-01
TP53-Mutant-vs-TP53-NonMutant
1.281400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
